These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report]. Stenner S, Enders G, Klee A, Eiden U, Weidner A, Gonser M. Z Geburtshilfe Neonatol; 2002 May; 206(3):102-6. PubMed ID: 12098826 [Abstract] [Full Text] [Related]
3. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report]. Banno S, Matsumoto Y, Sugiura Y, Ueda R. Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285 [Abstract] [Full Text] [Related]
5. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. Kalt M, Gertner E. J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178 [Abstract] [Full Text] [Related]
6. Maternal-fetal transmission of human parvovirus B19 genotype 3. Candotti D, Danso K, Parsyan A, Dompreh A, Allain JP. J Infect Dis; 2006 Sep 01; 194(5):608-11. PubMed ID: 16897659 [Abstract] [Full Text] [Related]
7. Detection of parvovirus B19 infection in first and second trimester fetal loss. de Krijger RR, van Elsacker-Niele AM, Mulder-Stapel A, Salimans MM, Dreef E, Weiland HT, van Krieken JH, Vermeij-Keers C. Pediatr Pathol Lab Med; 1998 Sep 01; 18(1):23-34. PubMed ID: 9566279 [Abstract] [Full Text] [Related]
8. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway? Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C. Eur J Intern Med; 2008 Jul 01; 19(5):314-8. PubMed ID: 18549931 [Abstract] [Full Text] [Related]
9. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S. Arthritis Rheum; 2003 Jul 01; 48(7):1939-47. PubMed ID: 12847688 [Abstract] [Full Text] [Related]
10. [Systemic manifestations of Parvovirus B19 infections]. Sève P, Ferry T, Charhon A, Calvet A, Broussolle C. Rev Med Interne; 2004 Oct 01; 25(10):740-51. PubMed ID: 15471600 [Abstract] [Full Text] [Related]
11. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection. Nyman M, Skjöldebrand-Sparre L, Broliden K. J Perinat Med; 2005 Oct 01; 33(2):176-8. PubMed ID: 15843271 [Abstract] [Full Text] [Related]
12. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Söderlund-Venermo M, Hedman K. J Clin Virol; 2006 Apr 01; 35(4):400-6. PubMed ID: 16332455 [Abstract] [Full Text] [Related]
13. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients. Chen DY, Chen YM, Lan JL, Tzang BS, Lin CC, Hsu TC. Clin Chim Acta; 2012 May 18; 413(9-10):855-60. PubMed ID: 22309679 [Abstract] [Full Text] [Related]
14. Intra-uterine parvovirus B19 infection and meconium peritonitis. Zerbini M, Gentilomi GA, Gallinella G, Morandi R, Calvi S, Guerra B, Musiani M. Prenat Diagn; 1998 Jun 18; 18(6):599-606. PubMed ID: 9664606 [Abstract] [Full Text] [Related]
15. Congenital parvovirus infection. Vogel H, Kornman M, Ledet SC, Rajagopalan L, Taber L, McClain K. Pediatr Pathol Lab Med; 1997 Jun 18; 17(6):903-12. PubMed ID: 9353830 [Abstract] [Full Text] [Related]
16. Hydrothorax as a sole manifestation of congenital parvovirus B19 infection. Sarafidis K, Drossou-Agakidou V, Evdoridou I, Petridou S, Hatzisevastou-Loukidou H, Dadamojas C, Roilides E. Am J Perinatol; 2008 Oct 18; 25(9):551-4. PubMed ID: 18773380 [Abstract] [Full Text] [Related]
17. Lupus syndrome after parvovirus B19 infection. Roblot P, Roblot F, Ramassamy A, Becq-Giraudon B. Rev Rhum Engl Ed; 1997 Dec 18; 64(12):849-51. PubMed ID: 9476277 [Abstract] [Full Text] [Related]